Sartorius Stedim Biotech
Sartorius | About Sartorius Stedim Biotech.
Launch date
Employees
Market cap
$20.0b
Enterprise valuation
$22.7b (Public information from Sep 2024)
Share price
€181.3 DIM.PA
Göttingen Lower Saxony (HQ)
Financials
Estimates*
| EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.9b | 2.9b | 3.5b | 2.8b | 2.8b | 3.0b | 3.4b |
| % growth | 33 % | 51 % | 21 % | (21 %) | - | 9 % | 12 % |
| EBITDA | 624m | 825m | 1.2b | 695m | 799m | 915m | 1.1b |
| % EBITDA margin | 33 % | 29 % | 35 % | 25 % | 29 % | 30 % | 32 % |
| Profit | 358m | 414m | 876m | 310m | 236m | 357m | 470m |
| % profit margin | 19 % | 14 % | 25 % | 11 % | 8 % | 12 % | 14 % |
| EV / revenue | 14.3x | 15.5x | 8.3x | 9.2x | 7.2x | 6.6x | 5.8x |
| EV / EBITDA | 43.9x | 54.4x | 23.5x | 36.9x | 25.3x | 21.9x | 18.5x |
| R&D budget | 84.5m | 110m | 132m | 130m | - | - | - |
| R&D % of revenue | 4 % | 4 % | 4 % | 5 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
£450k | Early VC | ||
£1.0m | Early VC | ||
£3.7m | Series A | ||
£1.0m | Series A | ||
| N/A | N/A | Seed | |
N/A | Seed | ||
| Total Funding | $8.1m | ||
Related Content
Recent News about Sartorius Stedim Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Sartorius Stedim Biotech
Edit
ACQUISITION by Sartorius Stedim Biotech Mar 2023
ACQUISITION by Sartorius Stedim Biotech Mar 2017
ACQUISITION by Sartorius Stedim Biotech Apr 2017
ACQUISITION by Sartorius Stedim Biotech Jul 2021
ACQUISITION by Sartorius Stedim Biotech Aug 2022
ACQUISITION by Sartorius Stedim Biotech Dec 2020
